BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

All Posts


CluePoints Introduces Medical & Safety Review Tool to Optimize Clinical Data Management

Sept. 27, 2024   by Roman Kasianov     News
CluePoints has launched the Medical & Safety Review (MSR) software, a new tool aimed at addressing inefficiencies in clinical data …
Continue ›››
BioAge Labs Targets Obesity with Upsized …

BioAge Labs Targets Obesity with Upsized IPO, Expected to Raise $198M to Fund Clinical Trials

Sept. 26, 2024   by Roman Kasianov     News
BioAge Labs (Richmond, CA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases such as obesity, has announced the pricing …
Continue ›››

Immunai and AstraZeneca Collaborate to Optimize Oncology Clinical Trials Using AI-driven Immune Mapping

Sept. 26, 2024   by Roman Kasianov     News
Immunai, a New York-based AI biotech company, has entered a multi-year collaboration with AstraZeneca to optimize oncology clinical trials. This …
Continue ›››
UK-based Laverock Therapeutics Expands Gene-Silencing Technology …

UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas

Sept. 26, 2024   by Roman Kasianov     --
Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at …
Continue ›››
Healthcare’s Cybersecurity Crisis: A Growing Threat …

Healthcare’s Cybersecurity Crisis: A Growing Threat Amid Outdated Technology

Sept. 25, 2024   by Roman Kasianov     News
As healthcare systems embrace digital transformation, the increased reliance on connected devices, platforms, and remote work environments has significantly expanded …
Continue ›››
Looking Back: How Etcembly's ETCh Study …

Looking Back: How Etcembly's ETCh Study is Uncovering New Cancer Targets from Survivors

Sept. 25, 2024   by Roman Kasianov     News
Despite advances in medical science, finding a cure for cancer remains an elusive goal. Currently, only half of all people …
Continue ›››
Generate Biomedicines Enters Up to $1 …

Generate Biomedicines Enters Up to $1 Billion Multi-Target Collaboration with Novartis to Use Generative AI for Protein Design

Sept. 24, 2024     News
Generate:Biomedicines has announced a multi-target collaboration with Novartis to develop protein therapeutics using its generative AI platform. The deal, valued …
Continue ›››
Immusoft Announces Positive Data for First …

Immusoft Announces Positive Data for First Engineered B Cell Therapy in Clinical Trial

Sept. 23, 2024   by Roman Kasianov     News
Immusoft, a biotech company focusing on cell therapy for rare diseases, has announced encouraging results from its Phase 1 clinical …
Continue ›››
ImageBloom Launches Patient Recruitment Marketplace for …

ImageBloom Launches Patient Recruitment Marketplace for Clinical Trials

Sept. 23, 2024   by Roman Kasianov     News
ImageBloom, Inc., a provider of clinical trial support services, has launched the Patient Recruitment Marketplace, a platform designed to address …
Continue ›››
Aston University Scientists Develop Gallium-Infused Glass …

Aston University Scientists Develop Gallium-Infused Glass Nanoparticles to Treat Osteosarcoma

Sept. 23, 2024   by Roman Kasianov     News
Scientists from Aston University in Birmingham, led by Professor Richard Martin, have developed gallium-infused bioactive glass nanoparticles for treating osteosarcoma, …
Continue ›››
Vortioxetine Shows Potential in Glioblastoma Treatment, …

Vortioxetine Shows Potential in Glioblastoma Treatment, Clinical Trials Planned

Sept. 21, 2024   by Roman Kasianov     News
ETH Zurich researchers have identified vortioxetine, an FDA-approved antidepressant, as a promising candidate in the fight against glioblastoma, a highly …
Continue ›››
Dandelion Health Launches AI Marketplace to …

Dandelion Health Launches AI Marketplace to Speed Up Clinical Trials with Real-World Data

Sept. 20, 2024     News
Dandelion Health, a health tech startup, has launched a clinical AI marketplace that combines third-party algorithms with its proprietary data …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.